ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 35.7 | 33.2 | 34.8 |
| Other income | 0.7 | 0.3 | 1.7 |
| Total income | 36.5 | 33.5 | 36.5 |
| Profit before exceptional items & tax | -6.4 | -8.2 | -6.8 |
| Profit before tax | -6.4 | -8.2 | -6.8 |
| Net profit | -6.1 | -8.1 | -6.4 |
| Operating margin | -17.5% | -24.5% | -18.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +2.60% |
|---|---|
| Operating profit, year on year | +16.50% |
| Operating profit, quarter on quarter | +16.50% |
BSE results filing, NSE: KERALAYUR. Figures extracted from the filing.
Kerala Ayurveda Ltd: key numbers
- Share price
- ₹151.10
- Market cap
- ₹181.8 Cr
- Revenue (annual)
- ₹131.2 Cr
- Net profit (annual)
- ₹-16.32 Cr
- P/E (TTM)
- -6.8×Sector 43.8×
- Promoter holding
- 38.70%+3.09% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kerala Ayurveda Ltd
All →Kerala Ayurveda Results Update
Kerala Ayurveda reported H1 FY27 revenue from operations of Rs.68.9 Crs, up 8.7%, with Q2 EBITDA losses narrowing. The press release reiterates targets for monthly operating EBITDA breakeven in H2 FY27 and a potential fund raise.
Kerala Ayurveda Board Meeting Date
Kerala Ayurveda has given prior intimation of a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. Trading window closes from 30 September 2026 until 48 hours after results are declared.
Kerala Ayurveda Capital Structure Change
Kerala Ayurveda's board approved allotment of 6,55,000 equity shares at Rs.190.37 to promoter-group entity Katra Holding, settled by adjusting an unsecured loan. This is a capital structure change, with corporate action still pending.
- Value
- ₹124.7 Cr
Kerala Ayurveda Preferential Issue
Kerala Ayurveda allotted 6,55,000 preferential shares to Katra Holding at Rs. 190.37 each, totaling Rs. 12.47 Crore. The existing unsecured loan was adjusted as consideration.
- Value
- ₹12.47 Cr
Kerala Ayurveda Other Announcement
Kerala Ayurveda Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026, as required by SEBI regulations.
Kerala Ayurveda Annual General Meeting
Kerala Ayurveda Ltd held its 34th Annual General Meeting on September 28, 2026, where shareholders discussed financial statements, director re-appointment, and preferential share issuance.